Kim CM - Search Results

1

p53 activation in response to mitotic spindle damage requires signaling via BubR1-mediated phosphorylation.

Ha GH, Baek KH, Kim HS, Jeong SJ, Kim CM, McKeon F, Lee CW. Ha GH, et al. Among authors: kim cm, kim hs. Cancer Res. 2007 Aug 1;67(15):7155-64. doi: 10.1158/0008-5472.CAN-06-3392. Cancer Res. 2007. PMID: 17671183

2

Caspases-dependent cleavage of mitotic checkpoint proteins in response to microtubule inhibitor.

Baek KH, Shin HJ, Jeong SJ, Park JW, McKeon F, Lee CW, Kim CM. Baek KH, et al. Among authors: kim cm. Oncol Res. 2005;15(3):161-8. doi: 10.3727/096504005776367906. Oncol Res. 2005. PMID: 16050137

3

Transcriptional abnormality of the hsMAD2 mitotic checkpoint gene is a potential link to hepatocellular carcinogenesis.

Jeong SJ, Shin HJ, Kim SJ, Ha GH, Cho BI, Baek KH, Kim CM, Lee CW. Jeong SJ, et al. Among authors: kim sj, kim cm. Cancer Res. 2004 Dec 1;64(23):8666-73. doi: 10.1158/0008-5472.CAN-03-3455. Cancer Res. 2004. PMID: 15574775

4

Overexpression of hepatitis C virus NS5A protein induces chromosome instability via mitotic cell cycle dysregulation.

Baek KH, Park HY, Kang CM, Kim SJ, Jeong SJ, Hong EK, Park JW, Sung YC, Suzuki T, Kim CM, Lee CW. Baek KH, et al. Among authors: kim sj, kim cm. J Mol Biol. 2006 May 26;359(1):22-34. doi: 10.1016/j.jmb.2006.03.020. Epub 2006 Mar 29. J Mol Biol. 2006. PMID: 16616934

5

Inhibition of histone deacetylase activity increases chromosomal instability by the aberrant regulation of mitotic checkpoint activation.

Shin HJ, Baek KH, Jeon AH, Kim SJ, Jang KL, Sung YC, Kim CM, Lee CW. Shin HJ, et al. Among authors: kim sj, kim cm. Oncogene. 2003 Jun 19;22(25):3853-8. doi: 10.1038/sj.onc.1206502. Oncogene. 2003. PMID: 12813458

6

Cyclooxygenase-2 (COX-2) is directly involved but not decisive in proliferation of human hepatocellular carcinoma cells.

Park JW, Park JE, Lee JA, Lee CW, Kim CM. Park JW, et al. Among authors: kim cm. J Cancer Res Clin Oncol. 2006 Mar;132(3):184-92. doi: 10.1007/s00432-005-0060-x. Epub 2005 Dec 6. J Cancer Res Clin Oncol. 2006. PMID: 16331492

7

Mutation analysis of p31comet gene, a negative regulator of Mad2, in human hepatocellular carcinoma.

Yun MY, Kim SB, Park S, Han CJ, Han YH, Yoon SH, Kim SH, Kim CM, Choi DW, Cho MH, Park GH, Lee KH. Yun MY, et al. Among authors: kim sb, kim sh, kim cm. Exp Mol Med. 2007 Aug 31;39(4):508-13. doi: 10.1038/emm.2007.56. Exp Mol Med. 2007. PMID: 17934339

8

Antitumor effects of systemically delivered adenovirus harboring trans-splicing ribozyme in intrahepatic colon cancer mouse model.

Jeong JS, Lee SW, Hong SH, Lee YJ, Jung HI, Cho KS, Seo HH, Lee SJ, Park S, Song MS, Kim CM, Kim IH. Jeong JS, et al. Among authors: kim ih, kim cm. Clin Cancer Res. 2008 Jan 1;14(1):281-90. doi: 10.1158/1078-0432.CCR-07-1524. Clin Cancer Res. 2008. PMID: 18172280

9

Alpha-fetoprotein and human telomerase reverse transcriptase mRNA levels in peripheral blood of patients with hepatocellular carcinoma.

Kong SY, Park JW, Kim JO, Lee NO, Lee JA, Park KW, Hong EK, Kim CM. Kong SY, et al. Among authors: kim jo, kim cm. J Cancer Res Clin Oncol. 2009 Aug;135(8):1091-8. doi: 10.1007/s00432-009-0549-9. Epub 2009 Jan 31. J Cancer Res Clin Oncol. 2009. PMID: 19184104

10

Practical efficacy of sorafenib monotherapy for advanced hepatocellular carcinoma patients in a Hepatitis B virus-endemic area.

Shim JH, Park JW, Choi JI, Park BJ, Kim CM. Shim JH, et al. Among authors: kim cm. J Cancer Res Clin Oncol. 2009 Apr;135(4):617-25. doi: 10.1007/s00432-008-0496-x. Epub 2008 Oct 10. J Cancer Res Clin Oncol. 2009. PMID: 18846384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

779 results

Search Page

Filters